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Abstract
Background: Little is known about HIV-1 subtype distribution in Morocco. Some data suggest an emergence of
new HIV subtypes. We conducted phylogenetic analysis on a nationally representative sample of 60 HIV-1 viral
specimens collected during 2004-2005 through the Morocco national HIV sentinel surveillance survey.
Results: While subtype B is still the most prevalent, 23.3% of samples represented non-B subtypes, the majority of
which were classified as CRF02_AG (15%). Molecular clock analysis confirmed that the initial introduction of HIV-1B
in Morocco probably came from Europe in the early 1980s. In contrast, the CRF02_AG strain appeared to be
introduced from sub-Saharan Africa in two separate events in the 1990s.
Conclusions: Subtype CRF02_AG has been emerging in Morocco since the 1990s. More information about the
factors introducing HIV subtype-specific transmission will inform the prevention strategy in the region.
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Introduction
HIV-1 variability remains a formidable challenge for
designing a protective vaccine or an effective cure. The
HIV-1 is divided into 4 groups: M, N, O and P. Group
M is responsible for the current pandemic and includes
more than 49 circulating recombinant forms (CRFs), 9
subtypes, 5 sub-subtypes, and unique recombinant
forms (URFs) [1,2]. HIV genetic diversity is generated
by the high rate of virus mutation, rapid viral turnover
and frequent recombination events between subtypes
[3]. Furthermore, there is an unequal geographic distri-
bution of HIV-1 subtypes and CRFs around the world
characterized by different epidemic behaviours and
growth rates [4]. For instance, in western Europe and
North America, subtype B is the most prevalent whereas
in sub-Saharan Africa subtypes A, C, D and CRF02_AG
predominate [5-7]. This geographic distribution of HIV-
1 subtypes could result from migration, travel, or geo-
graphic accessibility. These factors may contribute to
the transmission of these clades outside the regions
where they are most prevalent [8,9]. The increasing
diversity of HIV-1 underscores the need for diagnostics,
patient monitoring tools, and treatment options that are
effective across the full spectrum of known groups, sub-
types, and recombinant forms.
The first reported case of HIV/AIDS in Morocco
occurred in 1986. Up to December 2010, a cumulative
total of 2,914 persons have been diagnosed with AIDS
in Morocco, and estimates suggest approximately 26,000
persons are living with HIV in the country [10]. Among
them, 58% were identified during the 6 last years.
Furthermore, more than half of cases are from 3
regions: the Agadir region (22%), the Marrakech region
(16%) and the Casablanca region (14%). Young adults
(15-39 years) represent 64% of all the cases, and the
proportion of HIV infections in women has increased
from 18% (1986-1990) to more than 40% (2004-2008).
HIV-1 transmission is reportedly attributed to hetero-
sexual transmission in more than 80% of individuals.
A national HIV sentinel surveillance network has been
implemented in Morocco since 1993 [11]. This surveil-
lance is based on an anonymous, unlinked study and is
approved by the WHO Ethical Committee. Studied
groups include pregnant women, patients consulting
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any medium, provided the original work is properly cited.healthcare centres with STIs, persons with tuberculosis,
prisoners, injecting drug users (IDUs) and sex workers.
A study of HIV subtypes in Morocco from 1997
showed a predominance of HIV-1 subtype B (93.5%), a
pattern more similar to Europe than sub-Saharan Africa
[12]. More recently, an analysis of HIV subtypes from a
single region of Morocco suggests an increase in per-
sons with HIV CRF02-AG, which has typically been
associated with infections from sub-Saharan Africa [13].
Since the mid-1990s, Morocco has been experiencing a
significant immigration of persons from sub-Saharan
Africa, many of which are attempting to enter Europe.
More recently, Spain and the European Union have
intensified their border and coastal surveillance. Conse-
quently, Morocco has shifted from being a transit coun-
try to the final station for many migrants. Other
countries in the MENA region are also demonstrating a
more diverse HIV epidemic in terms of HIV subtype
distribution [14].
The study of HIV subtype distribution may reveal epi-
demiological patterns of transmission or distinct net-
works associated with specific risk behaviours.
Phylogenetic analysis can further expand the identifica-
tion of specific epidemiological clusters of HIV infection
from a common origin [9]. We investigated the pattern
of HIV-1 subtype diversity and high-resolution phyloge-
netic analysis of a representative sample of 60 HIV-
infected persons identified through the Morocco
national HIV sentinel surveillance program.
Materials and methods
Sample collection
Samples were collected as part of the sentinel surveil-
lance system, a national HIV epidemic AIDS surveil-
lance survey carried out each spring by the Moroccan
Ministry of Health to assess trends in the HIV epidemic.
The sera were collected from different regions of Mor-
occo during 2004 and 2005. All of the 60 HIV-positive
samples during the 2004-2005 survey were included in
this study. Samples were screened HIV-1 positive by
Elisa (HIV1/2 Genscreen plus, Bio-Rad, France) and
confirmed by Western blot test (Genlabs, USA). These
samples were representative of the different regions of
Morocco and were consistent with the age and sex dis-
tribution of reported HIV cases within the country
(Table 1).
PCR and DNA sequencing
To study diversity, samples were sequenced in pol gene
region [protease gene (PR) and 2/3 5’ region of the
reverse transcriptase gene (RT)]. The viral RNA was
extracted and PR and RT genes were RT-PCR amplified
as previously described [15]. The fragments obtained
were sequenced on both strands using an automated
sequencer Beckman CEQ 2000 DNA Analysis System,
and subtyped by using the Rega HIV-1 Subtyping tool
version 2.0 (http://dbpartners.stanford.edu/
RegaSubtyping).
GenBank accession numbers for the sequences
reported in this study are JQ316543 to JQ316600 and
JQ344156 to JQ344204 for PR and RT sequences
respectively.
Dataset assembling
All sequences from Morocco were divided into protease
(PR, N = 58) and reverse transcriptase (RT, N = 49)
alignments (Table 1). A set of full genome reference
sequences (Genbank:AF004885, Genbank:AB253421,
Genbank:AB253429, Genbank:AF286241, Genbank:
AF286237, Genbank:K03455, Genbank:AY423387, Gen-
bank:AY173951, Genbank:AY331295, Genbank:
DQ853463, Genbank:U52953, Genbank:U46016, Gen-
bank:AF067155, Genbank:AY772699, Genbank:K03454,
Genbank:AY371157, Genbank:AY253311, Genbank:
U88824, Genbank:AF077336, Genbank:AF005494, Gen-
bank:AF075703, Genbank:AJ249238, Genbank:
AY371158, Genbank:AJ249236, Genbank:AJ249237,
Genbank:AF377956, Genbank:AF084936, Genbank:
AF061641, Genbank:U88826, Genbank:AF190127, Gen-
bank:AF190128, Genbank:AF005496, Genbank:
EF614151, Genbank:AF082394, Genbank:AF082395,
Genbank:AJ249235, Genbank:AJ249239, Genbank:
AY271690) were downloaded from the Los Alamos HIV
database. An additional set of sequences of PR/RT for
subtypes HIV-1 CRF02-AG and subtype B were down-
loaded from the Los Alamos database. The criterion for
inclusion in this dataset included the following:
sequences were published, were not amplified in culture
and had a known location and year of sampling. The
HIV-1B dataset was reduced for computational practi-
cality and included representative sequences only from
major geographic areas. Multiple-sequence alignments
were obtained by codon-alignment with the CLUSTAL
algorithm, and subsequently manually edited for optimi-
zation (Alignments are available from the authors upon
request).
Phylogenetic analysis
M a x i m u ml i k e l i h o o d( M L )t rees were first inferred
using the Moroccan sequences and full genome refer-
ences sequences. Analyses were performed assuming
the GTR + Gamma model of nucleotide evolution. Sta-
tistical support was assessed by non-parametric boot-
strapping (number of replicates = 500) using PHYML
version 3.0 [16]. Sequences that clustered with a pure
subtype with a bootstrap value of > 80 were classified
as such. Sequences that clustered with the CRF02_AG
with a bootstrap value > 50 were classified as HIV-1
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Sample Code N° Origin Risk Group Sex Age Sub-type PR Subtype RT
N1BBB B Tetouan Patient with TB M 35 B B
N1CBB C Tetouan Patients with STI’sM 3 2B B
N1A B A Tetouan Patient with TB M 39 B
N2NBB N Rabat Male prisoners M 30 B B
N238B 38 Rabat Female SW in prison F 19 B
S4DBB D Casablanca Patients with STI’sF 4 1B B
S4EBB E Casablanca Patient with TB M 39 B B
S4Q1BB Q1 Casablanca Pregnant women F 19 B B
S3MBB M Beni-Mellal Male prisoners M 25 B B
S3LBB L Safi NA B B
S2J1BB J1 Marrakech Male prisoners M 28 B B
S136BB 36 Agadir Patients with STI’sF 3 5B B
S1B1BB B1 Agadir Female SW in MC F 28 B B
S1C1BB C1 Agadir Patients with STI’sF 3 0B B
S1D1BB D1 Agadir Marines M 28 B B
S1E1BB E1 Agadir Pregnant women F 38 B B
S1F1BB F1 Agadir Female SW in prison F 21 B B
S1G1BB G1 Agadir Female SW in prison F 21 B B
S1RBB R Agadir Patient with TB M 20 B B
S1VBB V Agadir Male prisoners M 24 B B
S1ZBB Z Agadir Patients with STI’sF 1 8B B
S1V1BB V1 Taroudant Pregnant women F 38 B B
S235BB 35 Marrakech Patients with STI’sM 3 9B B
SX2K1O1BB Marrakech NA B B
S2I1BB I1 Marrakech Patients with STI’sF 2 3B B
S2L1BB L1 Marrakech Pregnant women F 27 B B
S2M1BB M1 Marrakech Male prisoners M 25 B B
S2N1BB N1 Marrakech Male prisoners M 22 B B
S1WBB W Agadir Female SW in prison F 25 B B
S115DB 15 Agadir Male prisoners M 25 B B
S1A1DB A1 Agadir Male prisoners M 27 B B
S114DB 14 Oulad Taima Female SW in MC F 31 B B
S118DB 18 Oulad Taima Pregnant women F 30 B B
S3JBB J Safi Male prisoners M 28 B B
S29BB 9 Marrakech Patients with STI’sF 2 2B B
S216BB 16 Marrakech Patients with STI’sM 4 0B B
SX1K1O1BB Agadir NA 29 29 B B
S1H1BB H1 Agadir Pregnant women F 24 B B
S225B 25 Marrakech Male prisoners M 29 B
S240B 40 Chichaoua Patients with STI’s F 34 B
S28B 8 Chichaoua Patients with STI’s F 44 B
S311B 11 Safi Pregnant women F 26 B
S3KB K Safi Patients with STI’s F 41 B
S139B 39 Agadir Patients with STI’s F 25 B
S13B 3 Oulad Taima Female SW in MC F 29 B
S113 B 13 Oulad Taima Female SW in MC F 39 B
N319CC 19 Meknes Patients with STI’sF 2 1 C C
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subtype were assembled, and sequences from the same
subject with concordant subtypes in PR and RT were
concatenated. MLtrees were inferred using the final
alignments for each subtype using concatenated PR/RT
sequences. Analyses were performed assuming the
GTR + Gamma model of nucleotide evolution. Statisti-
cal support was assessed by non-parametric bootstrap-
ping (number of replicates = 500) using PHYML.
Molecular clock analysis
The evolutionary rate (nucleotide substitutions per site
per year) and the time of the most recent common
ancestor (TMRCA, years) of HIV-1B in Morocco were
inferred using sequences sampled at different time
points by the MCMC approach implemented in
BEAST [17]. The analyses were performed with the
same nucleotide substitution model described in the
previous section, and different coalescent priors (con-
stant, exponential and Bayesian Skyline Plot), assuming
a strict or a relaxed molecular clock [18]. An MCMC
was run for 100,000,000 generations with sampling
every 10,000
th generation. The results were visualized
in Tracer. The effective sample size (ESS) value for
each parameter was > 500 indicating sufficient mixing
of the Markov chain.
Results
Sixty HIV-1 positive sera were genotyped: 41 from the
south (68.3%), 14 (23.3%) from the center and 5 (8.3%)
from the North of Morocco. Sex distribution was 62%
females and 38% males, with an average age of 29 years.
T h er i s kg r o u p sr e p r e s e n t e di nt h es t u d ys a m p l e
included persons attending STI clinics (38.6%), male
prisoners (17.5%), female sex workers (15.8%), pregnant
women (14%), people with TB (8.8%), drug users (5.3%),
marines (1.7%) and hotel workers (1.7%) (Table 1).
The PR and RT sequences were both positive for 47
(78.3%) samples. Of these, 43 (91.5%) had concordant sub-
type assignments including 36 (83.7%) subtype B, 6 (14%)
CRF02_AG and 1 (2.3%) subtype C (Table 1). The remain-
ing 4 (8.5%) samples in which both PR and RT regions
were positive revealed discordant subtypes that represent
intersubtypes and/or inter-CRF recombinant viruses. They
include B/C, A/C, A/CRF01_AE and CRF02_AG/B which
are represented by one sample each. Finally, of the 13 spe-
cimens with HIV-1 subtype assignment for only one viral
region, 8 PR and 2 RT sequences were of subtype B and 3
PR sequences were of subtype CRF02-AG.
HIV-1 subtypes appeared to be differently distributed
in Moroccan geographic regions. Subtype B strains
appeared to be widely distributed with little geographic
compartmentalization from region to region, whereas
the single samples of subtype C, A/C, B/C and A/
CRF01_AE were all concentrated in the northern
regions of Morocco.
Figure 1 shows a ML tree, including HIV-1 subtype B
sequences from Morocco as well as worldwide reference
sequences downloaded from the HIV databases (http://
www.hiv.lanl.gov/content/index). Overall, Moroccan
strains are highly intermixed with reference strains from
different geographic regions, suggesting multiple intro-
ductions of subtype B in Morocco over a relatively long
period of time. Two highly supported monophyletic
clades (100% and 94.5% bootstrap support, respectively)
of Moroccan strains appear to be related to HIV-1B
sequences from Europe, whereas a third large clade
clustered together with sequences from the United
States, although the clade was only weakly supported by
bootstrapping (< 50%). The time of the most recent
common ancestor (TMRCA) of HIV-1B Moroccan
strains calculated by molecular clock analysis dated back
to 1983 (95% high posterior density intervals: 1975-
Table 1 Database of HIV sequences included in the study (Continued)
N124AC 24 Tanger Drug users M 27 A C
N220BC 20 Rabat Patient with TB F 33 B C
N241AAE 41 Rabat Patients with STI’s F 25 A AE
N3HAGAG H Meknes Pregnant women F 22 AG AG
N229AGAG 29 Rabat Patients with STI’s F 26 AG AG
N2QAGAG Q Rabat Patients with STI’s F 29 AG AG
N2OAG O Rabat Patients with STI’s F 29 AG
N2PAG P Rabat Patients with STI’s M 28 AG
N446AG 46 Oujda Patients with STI’s F 40 AG
S1TAGAG T Agadir Hotels workers M 35 AG AG
S1SAGB S Agadir Female SW in MC F 30 AG B
S27AGAG 7 Chichaoua Consultant for STI F 24 AG AG
S317AGAG 17 Safi Consultant for STI F 39 AG AG
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cent prior enforcing a relaxed molecular clock. Different
coalescence priors also produced very similar estimates
(data not shown).
Figure 2 shows a ML tree of Moroccan and reference
CRF02_AG strains available in HIV databases. In contrast
to the subtype B ML tree, the Moroccan strains are highly
localized in two distinct monophyletic clades related to
sequences from Cameroon and Senegal. Although the
result should be interpreted with caution, given the rela-
tively small number of available sequences for phylogenetic
comparison, the tree suggests two separate introductions
of CRF02_AG in Morocco from sub-Saharan Africa, dated
in 1995 and 1998 respectively, according to the constant
population size coalescent prior enforcing a relaxed mole-
cular clock. Again, different coalescence priors had little
effect on the estimates (data not shown).
Discussion
We present the first data on the molecular epidemiology
of HIV-1 in Morocco from the national HIV sentinel
surveillance survey data. As of 2005, subtype B is still
predominant (76.7%), yet following subtype B, there is a
high diversity of non-B subtypes, especially CRF02_AG
recombinant (15%). Geographic subtype repartition sug-
gests the co-evolution of a more ancient diffusion of
European subtype B, and of a more recent spread of
sub-Saharan African strains in some Moroccan regions.
These results demonstrate a high diversity of HIV-1
s t r a i n si nM o r o c c o .T h i si sd i f f e r e n tf r o mw h a tw a s
reported in 1997 where the distribution of subtype B, A
and F strains in Morocco were 93.5%, 1.0%, and 0.5%
respectively [12]. However, these results are consistent
with our previous results [19] and the more recent
results described from the Casablanca region [13].
These findings are also consistent with results described
in other countries of the region, including the neigh-
bouring West African countries [14]. The increase of
HIV non-B subtypes was also recently reported in many
Western Europe countries. Studies conducted in France,
Spain, Switzerland, and Portugal have found that the
proportion of non-B subtypes may exceed 20% [20,21].
Figure 1 HIV-1B Maximum likelihood (ML) trees. The ML tree includes HIV-1B Moroccan sequences for which we have RT and PR sequences,
as well as 46 subtype B reference sequences from the HIV database that were randomly chosen to represent major geographic areas in the
world. The tree was generated using the GTR+G model of nucleotide substitution using the concatenated RT and PR genes. Branches are drawn
in scale, according to the bar at the bottom, and colored to reflect geographic origin according to the legend of the figure. The number along
a branch indicates significant bootstrap support (> 65%). Sequences were named using the year of sampling preceded by the two letter county
code of origin, according to the HIV database guidelines.
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increasingly more prevalent among the non-B subtypes
in these Western European countries.
The overall incidence of HIV-1 in Morocco has been
increasing at approximately 15% per year since 2000.
The increasing incidence of HIV combined with the
identification of additional non-B subtypes raises con-
cerns regarding the control of the current epidemic.
The entry of new HIV recombinant viruses is likely the
consequence of active exchange between different popu-
lations, such as Moroccan groups at risk and persons
migrating through Morocco from sub-Saharan Africa.
Before 1997, the presence of Sub-Saharan African indivi-
duals in Morocco was mostly limited to students and
tourists. However, migration of people from sub-
Saharan Africa to and through Morocco has been
increasing since the late 1990s. In 2007, the Moroccan
Ministry of the Interior estimated that approximately
15,000 irregular migrants flow through Morocco each
year [22]. In response, the European Union has tigh-
tened its boarder control and immigration policies. As a
result, many of the migrants settle in Morocco, waiting
for an opportunity to cross into Europe. In addition,
regular and irregular migrants face many economic and
social issues that may increase their risk for HIV trans-
mission. For example, issues such as human trafficking
and prostitution could contribute to the circulation of
non-B HIV subtypes such as CRF02_AG throughout the
country.
The fact that subtype B was more distributed through-
out the country, especially in the big-touristic cities
(Agadir, Marrakech and Casablanca), suggest this
Figure 2 HIV-1 CRF02_AG Maximum likelihood (ML) trees. The ML tree includes HIV-1 Moroccan CRF02_AG sequences, for which we have
RT and PR sequences, together with 28 CRF02_AG strains downloaded from the HIV databases for which the full genome sequences were
available. The tree was generated using the GTR+G model of nucleotide substitution using the concatenated RT and PR genes. Branches are
drawn in scale, according to the bar at the bottom, and colored to reflect geographic origin according to the legend of the figure. The number
along a branch indicates significant bootstrap support (> 65%). Sequences were named using the year of sampling preceded by the two letter
county code of origin, according to the HIV database guidelines.
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subtype CRF02_AG were also widely distributed geogra-
phically; however, this subtype was not detected in Mor-
occo before 1997, suggesting a more recent epidemic.
These findings are also supported by our molecular
clock analysis. The other non-B subtypes and recombi-
nants represented more localised transmission due to C,
A/C, B/C and A/CRF01_AE strains in the northern part
of Morocco.
As the first case of HIV/AIDS in Morocco was
reported in 1986, there is an excellent agreement with
the TMRCA of HIV-1B of 1983 estimated by molecular
clock analysis. Since that date, HIV has been spreading
t h r o u g h o u tt h ec o u n t r y ,m a i n l yb yh e t e r o s e x u a lt r a n s -
mission [11]. According to the sentinel surveillance sys-
tem, the overall HIV prevalence is less than 1% in
Morocco. However, even though Morocco is a low pre-
valence epidemic, HIV/AIDS cases are steadily rising,
chiefly in the southern Morocco region of Agadir and
neighbouring areas that may represent the epicentre of
the epidemic within Morocco [23].
Our findings should be interpreted in light of study
limitations. While our analysis included all HIV positive
specimens from the 2004-2005 survey, the sample size
was relatively small. Therefore, it is not possible to gen-
eralise the results as a national trend in Morocco. In
addition, routes of transmission and clinical and immu-
nologic status of the HIV-infected individuals were not
available for this study, since they are not required in
the surveillance process. However, the present data
should prompt us to continue to track the molecular
epidemiology of the HIV virus in Morocco at the
national level. In this context, reinforcement of preven-
tive measures to limit the spread of the epidemic is cru-
cial. Lastly, by limiting our phylogenetic analysis to only
the pol gene region, we may have missed some recombi-
nants and therefore underestimated their distribution.
However, our main finding that CRF02_AG is increasing
in Morocco, signifying a shift from an epidemic pre-
viously dominated by serogroup B, remains true. In con-
clusion, the results of this study displayed that HIV
diversity is more dynamic in Morocco and its pattern is
shifting from the European to sub-Saharan one, i.e. with
more subtypes non-B, namely the CRF02_AG. However,
more studies to confirm the trend observed during this
study and to better characterize the molecular HIV epi-
demic in Morocco will be of great importance. When
taken together, these data demonstrate a dynamic evolu-
tion in the HIV diversity in Morocco. The emergence of
new HIV subtypes are characterised by an important
presence of non-B subtypes that appear to be linked to
sub-Saharan populations. More data are needed to bet-
ter understand the factors responsible for the
introduction and spread of new HIV-1 subtype epi-
demics into regions where they did not exist previously.
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